INTRODUCTION
============

Migraine is a recurrent primary headache disorder with a prevalence of 8.6% in males and 17.5% in females.[@B1] Migraines are among the most disabling and burdensome conditions.[@B2] The Global Burden of Disease Study ranked migraine as the seventh most common disabling pathology among 289 diseases, being referred to as the 7th disabler.[@B3] Migraine has a significant impact on both mental and physical health, since it can impair school or work performance so as to substantially decrease the quality of life, leading to social isolation.[@B3][@B4] The problem becomes even more significant when various comorbidities such as autoimmune, gastrointestinal (GI), and psychiatric diseases are taken into account.[@B3][@B5][@B6] Nevertheless, the pathophysiological mechanism of migraine remains elusive.[@B7] Several mechanisms such as inflammation, pain mediators such as calcitonin-gene-related peptide (CGRP), and neurotransmitters such as serotonin[@B8][@B9] are currently discussed; indeed, serotonin agonists such as triptans can relieve migraine, and selective serotonin-reuptake inhibitors and tricyclic antidepressants have been used successfully as prophylactic treatments.[@B8]

There is emerging research evidence for the GI system playing an important role in the pathophysiology of migraine.[@B5][@B8][@B10] A possible connection was initially prompted by the observation that GI symptoms such as nausea, vomiting, and gastroparesis constitute clinical hallmarks of migraine.[@B11][@B12] Moreover, abdominal migraine, a condition that presents with both migrainous and abdominal symptoms, suggests that a common mechanism underlies both affected systems.[@B13][@B14][@B15] Furthermore, migraines can often coexist with GI disorders (GID) such as inflammatory bowel disease (IBD), celiac disease (CD), irritable bowel syndrome (IBS), and *Helicobacter pylori* (*H. pylori*) infection (HPI).[@B8][@B16][@B17][@B18][@B19] Moreover, GI tract (GIT) microbiota have been implicated in the pathogenesis of more than 25 diseases with CNS effects, for which multiple mechanisms have been discussed, such as bacterial translocation secondary to an impaired intestinal barrier, migration of stimulated immune cells, and the systemic diffusion of microbial products or metabolites.[@B8][@B20] This complex interplay between the brain and GIT is referred to in the literature as the gut-brain axis, which involves immune, neuroendocrine, and metabolic pathways, although the precise pathophysiology linking the different GI entities with migraine remains unclear.[@B8][@B10]

This paper is aimed at clinicians due to there being little awareness in the broader medical community regarding this relationship.[@B1] We believe that a better understanding of this association is likely to lead to a GID being considered a potential cause of migraine headache, in turn leading to prompt diagnoses and in fundamental migraine treatments changing from being pure symptomatic to curative.

METHODS
=======

A PubMed search was conducted that included all papers reporting on headache associated with GI symptoms. No time restraint was set. The search was based only on papers written in English, and the keywords used were "headache," "gastrointestinal diseases," "migraine," and "hemicrania." Using these keywords in various combinations yielded the following results: "headache" AND "gastrointestinal diseases" identified 308 papers, "headache" AND "gastrointestinal disorders" identified 84 articles, "migraine" AND "gastrointestinal diseases" identified 126 articles, and "hemicrania" AND "gastrointestinal diseases" identified 1 article. Further articles were identified through a manual search of the initially revealed literature. Only original studies and case reports/series on possible mechanisms between migraine and GI symptomatology were included.

In total, 29 papers were included for the purposes of this review. Since a common pathophysiological mechanism for migraine associated with GID could not be identified, since the literature searched yielded too many findings of GID concomitant with migraine headache that each had its own pathophysiology, in the Discussion section we present in more detail the reviewed studies and report for each study the potential pathophysiological mechanisms offered by the authors. Since migraine is associated with multiple GI entities rather than a single GID, we have regrouped migraine studies in the Results section according to the associated GID in order to facilitate the overview. Further details on each reviewed study regarding demographics, study characteristics, and pathogenicity-associated parameters are tabulated in [Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, and [3](#T3){ref-type="table"}.

RESULTS
=======

While the pathophysiological mechanism(s) underlying migraine and GID remain(s) elusive, the clinical observations-although being largely anecdotal-suggest that there is an important relationship between these two conditions.

Irritable bowel syndrome
------------------------

Robbins[@B21] reported the case of a 20-year-old male experiencing periodic episodes of abdominal pain resembling cluster headache (CH), which lasted 30--120 minutes and manifested in the evenings at intervals of 2--8 weeks. He had also experienced infrequent episodic tension-type headache that did not occur during periods of abdominal pain. A diagnosis of IBS was made, and the eventual relationship between CH and IBS was supported by the observation of the effectiveness of CH prophylaxis (e.g., verapamil) in the treatment of IBS.[@B21] Food elimination for the therapeutic management of patients with migraine and IBS was evaluated by Aydinlar et al.[@B22] in a double-blind, randomized, controlled, cross-over clinical trial involving 21 patients. Food allergy seems to play an important role in migraine pathophysiology due to a hypothesized inflammatory response.[@B22] Those authors reported that the tailored elimination diet resulted in significant improvements in both migraine and IBS symptoms, possibly by reducing the inflammatory response. Watson et al.[@B23] postulated a hormonal cause relating headache and IBS, since 50% of their IBS patients had headache. A neuroendocrine mechanism as a common pathophysiological mechanism underlying IBS and migraine was also postulated by Soares et al.[@B24] Cole et al.[@B16] found that the likelihood of migraine was 40--80% higher in subjects with IBS than in those without IBS.

Celiac disease
--------------

Dimitrova et al.[@B25] showed in 502 patients that the prevalence of migraine was higher in patients with CD and IBD than in healthy controls. Some patients reported significant migraine improvement or resolution after consuming a gluten-free diet, and similar findings were also reported by Gabrielli et al.[@B26] Bürk et al.[@B27] reported on 20 patients with biopsy-proven CD and migraine, finding that a gluten-free diet reduced migraine symptoms in many cases. Alehan et al.[@B28] measured serum tissue transglutaminase IgA (tTGA) antibodies (an indicator for the presence of CD) in their cases (73 children with migraine) and controls (*n*=147). The prevalence of tTGA antibodies was higher in migraine patients, suggesting a relationship between migraine and CD. The pathophysiology underlying these two conditions remains unclear, but the authors suggested that multiple nutritional, immunological, and inflammatory factors could be involved in triggering migraine attacks.[@B28]

Inflammatory bowel disease
--------------------------

In a case-control study, Ben-Or et al.[@B29] examined the prevalence of neurological diseases with GID in 50 patients and 42 healthy subjects, and found that the prevalence of headache was higher in IBD patients than in the control subjects (46% vs. 7.1%). The authors hypothesized an autoimmune/inflammatory mechanism or even malabsorption as possible pathophysiological components. In a cross-sectional study involving 160 subjects (80 with IBD and 80 controls without IBD, with a mean age of 35 years), Cheraghi et al.[@B30] found that the prevalence of migraine was significantly higher in subjects with IBD (21.3% vs. 8.8%, *p*=0.027). A potential inflammatory pathophysiological mechanism underlying these two conditions was postulated by the authors.

Cyclic vomiting syndrome
------------------------

Cupini et al.[@B31] observed in a 19-year-old woman with cyclic vomiting syndrome (CVS) and migraine that calcium-channel antagonists such as flunarizine led to a significant improvement of the vomiting syndrome, which led the authors to postulate a common pathogenic mechanism underlying both conditions. A genetic, mitochondrial dysfunction in migraine pathogenesis was postulated by Zaki et al.[@B32] Those authors found mitochondrial polymorphisms to be strongly associated in migraine and CVS patients; CVS is considered a migraine-like condition presenting with similar prodromal symptoms of nausea and vomiting that is responsive to antimigraine medications. Likewise, Christensen et al.[@B33] found that the incidence of migraine headaches was higher in patients with CVS and diabetic gastropathy.

Food allergy
------------

Monro et al.[@B34] described nine patients with food-provoking migraine who were refractory to conventional migraine therapy, and found that dietary exclusion of the offending food resulted in improvement of the migraine. Alpay et al.[@B35] showed in a double-blind, randomized, controlled, cross-over trial involving 30 patients (28 females and 2 males with a mean age of 35 years) that diet restriction in migraineurs based on IgG antibodies reduced the frequency of their migraine attacks (from 9.0±4.4 to 6.2±3.8, *p*\<0.001, mean±SD; *p*\<0.001). The authors speculated that inflammatory mechanisms could play a role in migraine. In a randomized controlled trial, Mitchell et al.[@B36] investigated the use of food elimination based on the presence of IgG antibodies for the prevention of migraine. The 167 participants had migraine and intolerance to at least one foodstuff, and they were randomized to a sham diet (*n*=83) or the intervention diet (*n*=84). The authors noted a significant decrease in the number of migraines at 4 weeks, but only a small decrease (not statistically significant) over the 12-week study period.

The relation between migraine and allergens was also investigated by Bektas et al.,[@B37] who enrolled 98 subjects (49 with migraine and 49 healthy subjects, with mean ages of 38.3 and 36.9 years, respectively). The rate of positivity in the allergy test was 55.1% in the migraine group and 32.7% in the control group (*p*\<0.05). Allergy positivity was associated with the frequency but not the severity of attacks. An inflammatory mechanism triggered by allergens leading to the vasodilator phase of migraine and local meningeal inflammation was postulated by the authors.

In 1983, Egger et al.[@B38] reported that 98% of 88 children with severe frequent migraine recovered on an appropriate diet. The authors concluded that since a wide range of foods can provoke an attack, an allergic rather than a metabolic mechanism might be the underlying cause. However, the authors noted that the patients did not show greatly increased levels of IgE or IgE antibodies.

*Helicobacter pylori* infection
-------------------------------

A link between HPI and headache was suggested by Bradbeer et al.[@B4] after they observed that HPI eradication treatment improved the headache but not diffuse abdominal symptoms in a young girl. A particularly interesting finding was that the patient\'s mother-who was suffering equally from recurrent migraine and GI discomfort-exhibited *H. pylori* positivity; eradication therapy also led to the resolution of her symptoms. In a case-control study, Hosseinzadeh et al.[@B39] found that the IgG and IgM antibody titers against *H. pylori* differed significantly between 70 patients with migraine headache and control groups: the optical densities for IgG and IgM antibodies to *H. pylori* were 60.08±7.70 and 32.1±8.7 in the case group and 21.82±6.20 and 17.6±9.4 in the control group.[@B34] A serotonin-based pathophysiological mechanism underlying both *H. pylori* infection and migraine was hypothesized by the authors, and they emphasized the need to investigate *H. pylori* infection actively in migraine patients.

Equally, Yiannopoulou et al.[@B19] suggested a potential relationship between *H. pylori* infection as an independent environmental risk factor for migraine without aura. In their case-control study, 49 patients with migraine without aura were compared with 51 control subjects without a history of primary headache. They showed that the prevalence of *H. pylori* infection was significant higher in patients with migraine headache than in controls (*p*=0.016).

Functional gastrointestinal disorders
-------------------------------------

Boccia et al.[@B40] conducted a case-control study involving 50 migrainous children with functional GID and 19 control subjects, as well as 10 migrainous children without such disorders and nine healthy children in order to evaluate the effects of gastric stasis on migraine attacks. The gastric emptying time was shortened by using a calcium-channel blocker (flunarizine), which has demonstrated efficacy in the treatment of migraine attacks. Flunarizine treatment resulted in a remarkable improvement of both the GI and headache symptoms; although the clinical findings could not be definitively explained, the authors postulated that ion-channel mutations play a role in the pathogenesis of migraine.

The relationship between gastric stasis and migraine was also evaluated by Aurora et al.[@B41] in a case-control study involving 10 migraine patients along with 10 age- and sex-matched controls. The authors showed that gastric stasis is not only present ictally but also interictally (as measured by gastric scintigraphy). The finding of interictal gastric stasis suggests that nausea in migraine could be related to a central cause rather than to the gastric stasis-migraine may consequently not be an episodic manifestation in an otherwise healthy person, but rather represent the expression of a dysregulated autonomic system. This hypothesis was supported by the findings of Maniyar et al.,[@B42] who performed a positron-emission tomography study in the premonitory phase of nitroglycerin-induced migraine. Their subjects with nausea showed activation in the rostral dorsal medulla and periaqueductal gray, while no activation of these central structures related to nausea were seen in the nonnausea group.

Infantile colic
---------------

In a case-control study, Romanello et al.[@B43] investigated the association between migraine and infantile colic in 208 consecutive children aged between 6 to 18 years. Most (72.6%, *n*=151) of the children with migraine also suffered from infantile colic. The authors postulated a molecular link between these two conditions in the form of CGRP, which is released during migraine attacks and is potentially also involved in the pathogenesis of abdominal pain by causing inflammation of sensory GI neurons. In a multivariable analysis of a population-based, prospective 18-year follow-up cohort, Sillanpää and Saarinen[@B44] showed that infantile colic was significantly associated with a nearly threefold increase in the risk of future migraine without aura.

Endocrine mechanisms
--------------------

The involvement of CGRP was postulated by Kurth et al.[@B13] in their study of 99 patients with upper GI symptoms and migraine. They found that the prevalence of idiopathic dyspepsia was higher in patients with migraine than in healthy controls (*n*=488). A nine-year prospective study of 81 obese patients with migraine headache by Gunay et al.[@B9] showed improvement of migraine after bariatric surgery for weight loss. The resolution of migraine symptoms was independent of the improvement of migraine-associated comorbidities. Postoperative endocrine changes or reduction in the adipokine burden were discussed by those authors as potential contributing causes. Amery and Forget conducted a 51-Cr EDTA gut-permeability test, and found that gut permeability was significantly higher in 16 patients with recurrent abdominal pain than in 11 control children and 10 healthy young adults (*p*\<0.0006).[@B45] Recurrent abdominal pain in migrainous children may be due to increased gut permeability allowing compounds to pass the gut-blood barrier that induce cerebral vasoconstriction or exert damaging neuronal effects.

CONCLUSIONS
===========

The clinical and pathophysiological relationships between migraine and GID are intriguing. However, the reported data suffer from great heterogeneity in their gathering and analysis techniques, making a meaningful comparison between studies impossible. Definitive conclusions can therefore not be drawn yet. Furthermore, since migraine is associated with multiple GI conditions rather than one particular GI disease, there is no single pathophysiology interpretation of the association. The pathophysiological mechanisms remain elusive regardless of the GI diseases associated with migraine. Since GI bacteria have repeatedly been implicated in shaping the character of the immune system, including at remote locations,[@B46][@B47] it would be interesting to investigate whether modifying the gut microbiota or even adding probiotics could affect migraines.[@B8] For the time being, from a strict clinical point of view, an awareness of the potential relationship between these two disorders can lead to prompt diagnosis and appropriate therapy for a highly disabling condition.
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###### Demographic characteristics

![](jcn-13-215-i001)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors (year)                        Country     Sample size                          n (females/males)         Mean age, years
  ------------------------------------- ----------- ------------------------------------ ------------------------- -----------------------------------------
  Aamodt et al. (2008)[@B5]             Norway      43,782                               12,944/6,898              46.2

  Alehan et al. (2008)[@B28]            Turkey      220                                  41/32                     12.01

  Alpay et al. (2010)[@B35]             Turkey      30                                   28/2                      35

  Amery and Forget (1989)[@B45]         Belgium     16                                   NM                        NM

  Aurora et al. (2006)[@B41]            USA         10                                   NM                        24.1

  Aydinlar et al. (2013)[@B22]          Turkey      21                                   18/3                      38

  Bektas et al. (2017)[@B37]            Turkey      49/49                                41/8 (controls: NM)       38.38 (controls: 36.93)

  Ben-Or et al. (2015)[@B29]            Israel      50                                   24/26                     14.8

  Boccia et al. (2006)[@B40]            Italy       50                                   29/21                     8.6

  Bradbeer et al. (2013)[@B4]           Australia   1                                    1/0                       7

  Bürk et al. (2009)[@B27]              Germany     72                                   62/10                     51

  Cheraghi et al. (2016)[@B30]          Iran        80 (controls: 80)                    33/47 (controls: 36/44)   35.31 (controls: 34.69)

  Christensen et al. (2008)[@B33]       USA         67                                   52/15                     43.7

  Cole et al. (2006)[@B16]              USA         97,593                               70,475/27,118             NM

  Cupini et al. (2003)[@B31]            Italy       1                                    1/0                       19

  Dimitrova et al. (2013)[@B25]         USA         502                                  Controls (178: 109/69)\   Controls: 47.8\
                                                                                         CD (188: 150/38)\         CD: 45.3\
                                                                                         GS (25: 21/4)\            GS: 49.5\
                                                                                         IBD (111: 58/53)          IBD: 36.5

  Egger et al. (1983)[@B38]             UK          88                                   48/40                     9.83

  Gabrielli et al. (2003)[@B26]         Italy       90                                   63/27                     37

  Gunay et al. (2013)[@B9]              USA         81                                   65/16                     40

  Hirst and Noble (2009)[@B50]          UK          3                                    2/1                       Males: 55, females: 20.48

  Hosseinzadeh et al. (2011)[@B39]      Iran        70                                   46/24                     35

  Kurth et al. (2006)[@B13]             Germany     99                                   75/24                     41.5

  Maniyar et al. (2014)[@B42]           USA         27                                   24/3                      32

  Mitchell et al. (2011)[@B36]          UK          167 (sham diet: 83, true diet: 84)   Sham diet: 72/11\         47.7 (sham diet: 47.1, true diet: 48.3)
                                                                                         true diet: 75/9           

  Monro et al. (1984)[@B34]             UK          9                                    6/3                       45.7

  Park et al. (2013)[@B49]              Korea       109                                  95/14                     41

  Robbins (2014)[@B21]                  USA         1                                    0/1                       20

  Romanello et al. (2013)[@B43]         Italy       208                                  86/122                    NM

  Ruggieri et al. (2008)[@B48]          Italy       835                                  604/231                   7.8

  Sillanpää and Saarinen (2015)[@B44]   Finland     787                                  434/356                   18

  Soares et al. (2013)[@B24]            Brazil      330                                  177/173                   Group I: 27.6\
                                                                                                                   Group II: 34.6\
                                                                                                                   Group III: 34.6

  Watson et al. (1978)[@B23]            UK          90                                   90/0                      NM

  Yiannopoulou et al. (2007)[@B19]      Greece      49                                   37/12                     31

  Zaki et al. (2009)[@B32]              USA         CVS: 30, adult MoA: 112              CVS: 21/9; MoA: NM        NM
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

CD: celiac disease, CVS: cyclic vomiting syndrome, GS: gluten sensitivity, IBD: inflammatory bowel disease, MoA: migraine without aura, NM: not mentioned.

###### Study design

![](jcn-13-215-i002)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors (year)                        Main GI disease                     Comorbidities                                                                  Migraine duration, years                     Inclusion criteria                                                                                                                                                                                                                   Exclusion criteria                                                                                                                       Maximum follow-up, months
  ------------------------------------- ----------------------------------- ------------------------------------------------------------------------------ -------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------------
  Aamodt et al. (2008)[@B5]             Reflux                              NM                                                                             1                                            1\. Age \>20 years\                                                                                                                                                                                                                  NM                                                                                                                                       NM
                                                                                                                                                                                                        2. ≥1 headache in previous year                                                                                                                                                                                                                                                                                                                                               

  Alehan et al. (2008)[@B28]            CD                                  NM                                                                             1                                            1\. Age 6--17 years\                                                                                                                                                                                                                 See inclusion criteria                                                                                                                   NM
                                                                                                                                                                                                        2. IHS criteria                                                                                                                                                                                                                                                                                                                                                               

  Alpay et al. (2010)[@B35]             Food allergy                        NM                                                                             13±9 (mean±SD)                               1\. ≥4 attacks or headaches/month\                                                                                                                                                                                                   1\. Medication overuse\                                                                                                                  6 weeks
                                                                                                                                                                                                        2. Age 18--55 years\                                                                                                                                                                                                                 2. Pure menstrual migraine                                                                                                               
                                                                                                                                                                                                        3. Treatment only with acute/preventive medication unchanged for ≥3 months\                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                        4. Cooperation                                                                                                                                                                                                                                                                                                                                                                

  Amery and Forget (1989)[@B45]         Recurrent abdominal pain disorder   NM                                                                             NM                                           Recurrent abdominal pain                                                                                                                                                                                                             NM                                                                                                                                       NM

  Aurora et al. (2006)[@B41]            Gastric stasis                      NM                                                                             NM                                           1\. Migraineurs (IHS)\                                                                                                                                                                                                               1 Daily usage of centrally acting medications\                                                                                           NM
                                                                                                                                                                                                        2. Sensitivity to visual triggers                                                                                                                                                                                                    2. Egg allergy\                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                             3. Prokinetic substances\                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                             4. Frequent tension-type headaches, chronic headache, and/or chronic opioid use                                                          

  Aydinlar et al. (2013)[@B22]          IBS                                 NM                                                                             10.8                                         1\. Migraine duration \>6 months and at least 2 migraine attacks and 4 headache days during the previous month\                                                                                                                      1\. Medication-overuse headache, pure menstrual migraine\                                                                                4.5
                                                                                                                                                                                                        2. Age 18--65 years\                                                                                                                                                                                                                 2. IBD, CD, lactose intolerance\                                                                                                         
                                                                                                                                                                                                        3. Abdominal discomfort lasting ≥12 weeks during previous year\                                                                                                                                                                      3. Major abdominal surgery                                                                                                               
                                                                                                                                                                                                        4. Preventive medications unchanged for ≥6 months                                                                                                                                                                                                                                                                                                                             

  Bektas et al. (2017)[@B37]            Food allergy                        NM                                                                             5.5                                          1\. Migraine without aura and healthy controls                                                                                                                                                                                       1\. History of allergy or systemic illness\                                                                                              NM
                                                                                                                                                                                                                                                                                                                                                                                                                                             2. Intake of H2-receptor blockers or antiallergic medication\                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                             3. Antidepressantants discontinued \<1 week prior to study beginning                                                                     

  Ben-Or et al. (2015)[@B29]            IBD                                 NM                                                                             0.75 (mean)                                  1\. Clinically and histologically proven IBD\                                                                                                                                                                                        NM                                                                                                                                       NM
                                                                                                                                                                                                        2. Questionnaire                                                                                                                                                                                                                                                                                                                                                              

  Boccia et al. (2006)[@B40]            Diffuse GI symptoms                 NM                                                                             NM                                           1\. Questionnaire\                                                                                                                                                                                                                   NM                                                                                                                                       2
                                                                                                                                                                                                        2. Rome II criteria for functional dyspepsia, IBS, functional abdominal pain, abdominal migraine, CVS\                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                        3. Functional vomiting (adult FGID criteria)                                                                                                                                                                                                                                                                                                                                  

  Bradbeer et al. (2013)[@B4]           *H. pylori* infection               None                                                                           8 months                                     NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Bürk et al. (2009)[@B27]              CD                                  1\. Depression\                                                                8                                            Biopsy-proven diagnosis                                                                                                                                                                                                              NM                                                                                                                                       NM
                                                                            2. Personality changes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                            3. Psychosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                            4. Hashimoto's disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Cheraghi et al. (2016)[@B30]          IBD                                 NM                                                                             NM                                           1\. Age \>18 years\                                                                                                                                                                                                                  1\. Head trauma\                                                                                                                         NM
                                                                                                                                                                                                        2. IBD\                                                                                                                                                                                                                              2. Vascular complications\                                                                                                               
                                                                                                                                                                                                        3. Informed consent                                                                                                                                                                                                                  3. Head or neck surgery\                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                             4. Brain tumor\                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                             5. Lumbar puncture                                                                                                                       

  Christensen et al. (2008)[@B33]       DGP                                 NM                                                                             NM                                           NM                                                                                                                                                                                                                                   Other identifiable causes of nausea and vomiting                                                                                         NM

  Cole et al. (2006)[@B16]              IBS                                 1\. Depression\                                                                NM                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM
                                                                            2. Fibromyalgia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Cupini et al. (2003)[@B31]            CVS                                 1\. Epilepsy                                                                   Since infancy                                NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Dimitrova et al. (2013)[@B25]         CD with IBD                         NM                                                                             NM                                           NM                                                                                                                                                                                                                                   1\. Past medical history of a disorder commonly contributed to headache\                                                                 NM
                                                                                                                                                                                                                                                                                                                                                                                                                                             2. Lumbar puncture within the past 3 years\                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                             3. Past surgeries of the head and neck\                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                             4. Dual diagnoses\                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                             5. Alcohol consumption \>14 units/week or not reporting weekly alcohol intake\                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                             6. \>4 cups of coffee/day or not reporting daily caffeine intake\                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                             7. Current drug use                                                                                                                      

  Egger et al. (1983)[@B38]             Food allergy                        NM                                                                             0.5--11                                      ≥1 headache/week during the previous year with ≥2 of the following: pallor, nausea, abdominal pain, photophobia, visual disturbances, giddiness/weakness, paresthesia                                                                Headaches due to middle-ear disease, sinusitis, refractive errors, dental disease, raised blood pressure, or intracranial hypertension   0

  Gabrielli et al. (2003)[@B26]         CD                                  NM                                                                             NM                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       6

  Gunay et al. (2013)[@B9]              Roux-en-Y gastric bypass            1\. Sleep apnea, menstrual dysfunction, depression, anxiety\                   22.6                                         1\. Preoperative migraine with antimigraine medication use\                                                                                                                                                                          1\. See inclusion criteria\                                                                                                              38.6
                                                                            2. Hypertension, hyperlipidemia, type 2 diabetes mellitus                                                                   2. Postoperative follow-up of \>12 months                                                                                                                                                                                            2. Physician-diagnosed idiopathic intracranial hypertension carefully identified to exclude them from the Migraine-Headache study        

  Hirst and Noble (2009)[@B50]          Cancer                              Esophageal cancer, ovarian germ-cell tumor, severe intractable nausea          3 months (pt 1), 4 years (pt 2), NM (pt 3)   NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Hosseinzadeh et al. (2011)[@B39]      *H. pylori* infection               Reflux, gastric ulcer, gastritis                                               NM                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Kurth et al. (2006)[@B13]             Upper abdominal symptoms            NM                                                                             NM                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Maniyar et al. (2014)[@B42]           Nausea                              NM                                                                             NM                                           1\. Age 18--65 years 2. Migraine without aura 3. \<15 days of headache/month 4. Premonitory symptoms before headache 5. No major medical conditions, and not taking preventive drugs for migraine or any other regular medications   Migraine aura                                                                                                                            NM

  Mitchell et al. (2011)[@B36]          Food allergy                        NM                                                                             ≥1                                           1\. Age 18--65 years 2. Self-diagnosed migraine for ≥12 months 3. No comorbidity 4. ≥2 migraine attacks/month 5. At least one food intolerance identified by ELISA                                                                   See inclusion criteria                                                                                                                   3

  Monro et al. (1984)[@B34]             Food allergy                        NM                                                                             NM                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Park et al. (2013)[@B49]              Functional GI symptoms              1\. Headache-related disability\                                               9.8                                          NM                                                                                                                                                                                                                                   1\. Severe systemic disease\                                                                                                             NM
                                                                            2. Psychological comorbidities                                                                                                                                                                                                                                                                                                                                   2. History of abdominal surgery\                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                             3. GI disorder\                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                             4. Analgesics for headache \>10 times during previous 3 months                                                                           

  Robbins (2014)[@B21]                  IBS                                 Episodic tension-type headache (no attacks during periods of abdominal pain)   14                                           NM                                                                                                                                                                                                                                   NM                                                                                                                                       NM

  Romanello et al. (2013)[@B43]         Infantile colic                     1\. Asthma\                                                                    NM                                           1\. Migraine and tension-type headache\                                                                                                                                                                                              Primary headaches                                                                                                                        NM
                                                                            2. Diabetes\                                                                                                                2. Age 6--18 years                                                                                                                                                                                                                                                                                                                                                            
                                                                            3. rUTI\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                            4. SCD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Ruggieri et al. (2008)[@B48]          GS                                  1\. Neurofibromatosis type 1 & 2\                                              NM                                           1\. Pediatric population from southern Italy\                                                                                                                                                                                        NM                                                                                                                                       8.7
                                                                            2. Tuberous sclerosis complex\                                                                                              2. GS with or without enteropathy                                                                                                                                                                                                                                                                                                                                             
                                                                            3. Complex malformation syndromes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                            4. Cerebellar degeneration\                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                            5. Multiple sclerosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                            6. Known leukodystrophies\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                            7. Ataxia-telangiectasia\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                            8. Congenital myasthenia syndromes\                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                            9. Congenital muscular dystrophies                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Sillanpää and Saarinen (2015)[@B44]   Infantile colic                     1\. Allergic diseases 2. Backache 3. Sleep disturbances                        NM                                           Questionnaire/visits                                                                                                                                                                                                                 NM                                                                                                                                       210

  Soares et al. (2013)[@B24]            IBS                                 NM                                                                             NM                                           1\. Rome III criteria for IBS\                                                                                                                                                                                                       Diagnostic suspicion of organic disease of GIT                                                                                           NM
                                                                                                                                                                                                        2. ICHD-II criteria for primary headache                                                                                                                                                                                                                                                                                                                                      

  Watson et al. (1978)[@B23]            IBS                                 IBS                                                                            NM                                           IBS                                                                                                                                                                                                                                  1\. Abuse of laxatives 2. Pathological sigmoidoscopy                                                                                     NM

  Yiannopoulou et al. (2007)[@B19]      *H. pylori* infection               *H. pylori* infection                                                          1--20                                        Migraine without aura                                                                                                                                                                                                                NM                                                                                                                                       NM

  Zaki et al. (2009)[@B32]              CVS                                 (Neuromuscular disease)                                                                                                     Positive for mtDNA haplogroup H                                                                                                                                                                                                      See inclusion criteria                                                                                                                   NM
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CD: celiac disease, CVS: cyclic vomitings syndrome, DGP: diabetic gastropathy, ELISA: enzyme linked immunosorbent assay, FGID: functional gastrointestinal disorders, GI: gastrointestinal, GIT: gastrointestinal tract, GS: gluten sensitivity, *H. pylori*: *Helicobacter pylori*, IBD: inflamatory bowel disease, IBS: irritable bowel syndrome, ICHD: International Classification of Headache Disorders, IHS: International Headache Society, NM: not mentioned, pt: patient, rUTI: recurrent urinary tract infection, SCD: Sickle-cell disease.

###### GI manifestations and possible pathogenetic mechanisms underlying the correlation between the CNS and GID

![](jcn-13-215-i003)

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors (year)                        GI symptoms                                                                                       Likely mechanism underlying GID/CNS correlation
  ------------------------------------- ------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------
  Aamodt et al. (2008)[@B5]             1\. Reflux\                                                                                       Autonomic nervous system dysfunction
                                        2. Constipation\                                                                                  
                                        3. Nausea                                                                                         

  Alehan et al. (2008)[@B28]            Study focus: asymptomatic CD                                                                      Autoimmune mediated

  Alpay et al. (2010)[@B35]             NM                                                                                                Inflammation induced by allergen-specific IgG or mediated by histamine

  Amery and Forget (1989)[@B45]         Periumbilical pain                                                                                Increased gut permeability, leading to cerebral vasoconstriction

  Aurora et al. (2006)[@B41]            Nausea                                                                                            Autonomic nervous system dysfunction (in migraineurs) and gastric stasis

  Aydinlar et al. (2013)[@B22]          Pain, bloating, diarrhea, and constipation                                                        Immunological and inflammatory process

  Bektas et al. (2017)[@B37]            1\. Nausea\                                                                                       Allergens may lead to activation of trigeminal afferents through an enhancement of the release of inflammatory mediators
                                        2. Vomiting                                                                                       

  Ben-Or et al. (2015)[@B29]            1\. Abdominal pain\                                                                               Autoimmune process or cross-reactivity; inflammatory process, malabsorption with hypovitaminosis
                                        2. Diarrhea\                                                                                      
                                        3. Weight loss\                                                                                   
                                        4. Anal fistulas                                                                                  

  Boccia et al. (2006)[@B40]            1\. Functional vomiting\                                                                          Channelopathy
                                        2. Functional abdominal pain                                                                      

  Bradbeer et al. (2013)[@B4]           Intermittent diffuse abdominal discomfort with nausea (independent of headaches)                  Infected gastric mucosa that activates proinflammatory factors, which induce systemic vasospasm

  Bürk et al. (2009)[@B27]              NM                                                                                                Immune hypothesis

  Cheraghi et al. (2016)[@B30]          NM                                                                                                Anxiety as well as inflammation via CRP, MMP-9, cytokines, and adhesion molecules

  Christensen et al. (2008)[@B33]       Bloating, early satiety, abdominal pain, nausea, vomiting (all parameters separately graduated)   Mitochondrial, metabolic, endocrine factors, vagal cholinergic dysfunction

  Cole et al. (2006)[@B16]              NM                                                                                                Common pathological pathway

  Cupini et al. (2003)[@B31]            Nonspecific GI symptoms                                                                           Mitochondrial DNA mutations, ion channelopathies, excessive endocrine dysfunction, heightened autonomic reactivity, genetic factors

  Dimitrova et al. (2013)[@B25]         NM                                                                                                1\. Inflammatory process (CRP, MMP-9, cytokines, adhesion molecules, NF-κB, iNOS)\
                                                                                                                                          2. Immunological process

  Egger et al. (1983)[@B38]             1\. Abdominal pain, diarrhea, flatulence\                                                         1\. Allergic reaction topical in the gut and release of mediators or in systemic circulation of antibody-antigen-complex\
                                        2. Recurrent mouth ulcers                                                                         2. Platelet dysfunction

  Gabrielli et al. (2003)[@B26]         Recurrent abdominal pain, chronic diarrhea, bloating                                              Autoimmune process

  Gunay et al. (2013)[@B9]              NM                                                                                                1\. Inflammatory mediators and endocrine hormones (neuropeptides)\
                                                                                                                                          2. Psychological factors: stress, anxiety, depression\
                                                                                                                                          3. Behavioral factors: sleep disturbances, sleep apnea, dietary irregularities, low physical activity

  Hirst and Noble (2009)[@B50]          Nausea, vomiting                                                                                  Impaired autonomic function

  Hosseinzadeh et al. (2011)[@B39]      Nonspecific GI symptoms                                                                           Serotonin mediated (secondary to *H. pylori*induction)

  Kurth et al. (2006)[@B13]             Abdominal pain, dyspepsia                                                                         Abnormal visceral mechanosensory, vagal function, CGRP

  Maniyar et al. (2014)[@B42]           Nausea                                                                                            Nausea, which leads to activation of NTS, dorsal motor nucleus of the vagus, nucleus ambiguus, or PAG\
                                                                                                                                          Nausea as a primary event of migraine

  Mitchell et al. (2011)[@B36]          1\. Nausea\                                                                                       NM
                                        2. Diarrhea                                                                                       

  Monro et al. (1984)[@B34]             NM                                                                                                Immunologically mediated via immune complexes containing IGE

  Park et al. (2013)[@B49]              1\. IBS\                                                                                          Mitochondrial dysfunction, which causes nervous system dysfunction
                                        2. Nausea and vomiting disorders\                                                                 
                                        3. Functional esophageal disorders\                                                               
                                        4. Functional dyspepsia\                                                                          
                                        5. Functional bloating                                                                            

  Robbins (2014)[@B21]                  IBS symptoms                                                                                      Neuroendocrine abnormalities of the hypothalamus

  Romanello et al. (2013)[@B43]         Abdominal pain                                                                                    CGRP mediation

  Ruggieri et al. (2008)[@B48]          GS symptomatology                                                                                 Hypothesis: GS-associated antibodies inducing neurotoxicity

  Sillanpää and Saarinen (2015)[@B44]   Infantile colic                                                                                   NM

  Soares et al. (2013)[@B24]            NM                                                                                                Role of brain--gut axis, neuroimmune and neuroendocrine interactions

  Watson et al. (1978)[@B23]            IBS symptoms                                                                                      Hormonal mechanism

  Yiannopoulou et al. (2007)[@B19]      NM                                                                                                Chronic immunoinflammatory response, which induces systemic vasculopathy

  Zaki et al. (2009)[@B32]              1\. Nausea\                                                                                       Mitochondrial dysfunction
                                        2. Vomiting\                                                                                      
                                        3. Abdominal pain                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CD: celiac disease, CGRP: calcitonin-gene-related peptide, CNS: central nervous system, CRP: C-reactive protein, GI: gastrointestinal, GID: gastrointestinal disorders, GS: gluten sensitivity, *H. pylori*: *Helicobacter pylori*, IBS: irritable bowel syndrome, IGE: Immunoglobulin E, iNOS: inducible nitric oxide synthase, MMP-9: matrix metallopeptidase-9, NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells, NM: not mentioned, NTS: nucleus tractus solitarius, PAG: periaqueductal gray.
